Skip to content

U-100 unit conversion

Bronchogen calculator

Convert mass and volume to U-100 units. No dose is selected.

These are example numbers so you can see the math. Try yours. Change them to match the vial in your hand.

2.5U-100 units · 0.025 mL

100 mcg per unit · 10000 mcg/mL

That draw is under 5 units, so the barrel is easy to misread. Check your inputs and measuring equipment with a qualified professional. The page does not select a dose or preparation.

How the calculator works, sources and review dates

Bronchogen math uses the listed vial sizes on this card and the liquid you type. Concentration in mcg per mL is vial milligrams times 1000, divided by milliliters. A U-100 syringe has 100 marks per milliliter, so each unit is that concentration divided by 100. Example numbers so you can see the math: a 20 mg listing plus 2 mL of liquid. Change any number and the units change. Try the numbers. A research-market vial is not the same material used in a trial.

Editorial review 2026-10-10. source-curated; clinician review pending.

Units chart for listed Bronchogen sizes

U-100 math for listed Bronchogen sizes. Each cell is micrograms per syringe mark if you add that much liquid. The table does the same math as the calculator. It does not pick an amount for you.

Micrograms per U-100 unit (100 marks / mL)
Listed vial1 mL liquid2 mL liquid3 mL liquid
20 mg20010066.7

What is Bronchogen?

Other names in the library: Bronchogen Peptide 20mg. Evidence describes the named substance, not a quality certification or equivalence assessment of commercial stock. Listed sizes: 20 mg. A seller title is a listing. It does not prove the vial matches a paper.

What the evidence says

For each trial, check who or what was studied, which preparation was used and what the findings support before comparing it with personal reports about individual experiences or seller listings that describe a product but don’t establish that it works.

Regulatory context

Regulatory context; not efficacy evidence

No matched controlled patient-efficacy study of this exact supplier preparation was verified.

Reported findings. Background context only. Matched evidence for the exact marketed formulation is not established by this reference.

Nonresponse. Nonresponse frequency not established in this excerpt.

Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.

Limits. Mechanistic or cellular bioregulator research cannot establish a clinical benefit for this supplier product.

Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Lab or animal research

Bronchogen: human-derived cell experiments

Human embryonic cell cultures; no treated-patient outcomes.

Reported findings. Researchers reported differentiation-marker changes in human embryonic cell cultures.

Nonresponse. Nonresponse frequency not established in this excerpt.

Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.

Limits. Human-derived tissue experiments are preclinical evidence, not human therapeutic outcomes. Exact supplier identity and clinical benefit remain unresolved.

Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Lab or animal research

Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Rats with Obstructive Lung Pathology.

Rats with COPD-like obstructive pathology after 60-day intermittent nitrogen-dioxide exposure; not treated humans.

Reported findings. Authors reported reduced epithelial remodeling/inflammation, restored ciliated cells and increased secretory IgA after peptide treatment.

Nonresponse. Nonresponse distribution and null endpoints were not specified in the abstract.

Harms. Harms and systematic safety assessment were not established in the abstract.

Limits. Sample size, randomization/blinding and route were not established in the reviewed abstract. Other Bronchogen papers name conflicting Ala-Asp-Glu-Leu and Ala-Glu-Asp-Leu sequences; do not silently equate either to this experimental preparation or catalog material. Animal bronchial findings do not establish human respiratory treatment efficacy.

Preparation: Named experimental Bronchogen tetrapeptide; original abstract does not verify sequence or equivalence to commercial material. Route: Not specified in reviewed original abstract; do not infer.

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Human report

Bronchogen: self-reported home respiratory measurements

One anonymous firsthand public reporter; outcomes and preparation not independently verified.

Reported findings. Reporter describes home peak-expiratory-flow readings rising from 490 to 574 L/min during the first exposure period, with a later rise on resumption. FEV1 changes are described as less clear; measurements were not independently validated.

Nonresponse. Readings tapered after exposure ended; reporter does not claim acute albuterol-like relief or cure. Post-off decline is recurrence, not demonstrated withdrawal.

Harms. No harms established in the inspected public account; absence of reporting does not establish safety.

Limits. Reported-name Bronchogen exposure only; sequence AEDL versus ADEL, terminal groups, purity and actual preparation are unverified. This does not resolve catalog chemistry or promote different-sequence laboratory studies. Anonymous self-selected firsthand public reporting without controlled comparison or independent assessment; not causal proof, clinical efficacy, a population response rate or established safety. Original bodies were visible through the web tool. Raw HTTP retrieval of these four URLs was not attempted after the prior separately recorded Reddit host403. Full-response hashes are null; excerpt hashes identify selected text only. Exact original publication timestamps remain unverified; relative ages, footer dates and index dates must not substitute. BPC157 and TB500 are explicitly concurrent; albuterol history/use, intermittent illness and resistance training complicate attribution. Inexpensive home spirometer, inconsistent testing, no FVC measurement, long gaps between measurements and sparse fitted trendlines; no controlled pulmonary assessment. Reporter noticed no sleep disruption, anaphylaxis or irritation; this self-reported absence is not a general safety conclusion. Earlier linked 163oy3x is the same reporter and is not counted as another independent person. Background geroprotection/DNA/cancer claims are not treated as observed outcomes. Three distinct publicly visible report groups are counted conservatively; anonymous people, exposures and independence cannot be independently verified.

Preparation: Publicly named Bronchogen preparation; AEDL/ADEL sequence and actual chemical identity unverified. Route: Subcutaneous explicitly stated in original post.

Read original source ↗

Editorial review 2026-10-10. Clinician review pending.

Human report

Bronchogen-thread firsthand comment: airway improvement, flushing and heart-rate increase

One anonymous firsthand public reporter; outcomes and preparation not independently verified.

Reported findings. Reporter describes airway clearing, deeper breaths with less coughing/phlegm/wheezing, and perceived easier exercise.

Nonresponse. Reporter describes prior breathing/allergy difficulties recurring during pauses; not demonstrated withdrawal.

Harms. Immediate flushing and a brief reported heart-rate increase to 106 bpm for about 3 minutes, followed by return toward the reporter's stated baseline.

Limits. Reported-name Bronchogen exposure only; sequence AEDL versus ADEL, terminal groups, purity and actual preparation are unverified. This does not resolve catalog chemistry or promote different-sequence laboratory studies. Anonymous self-selected firsthand public reporting without controlled comparison or independent assessment; not causal proof, clinical efficacy, a population response rate or established safety. Original bodies were visible through the web tool. Raw HTTP retrieval of these four URLs was not attempted after the prior separately recorded Reddit host403. Full-response hashes are null; excerpt hashes identify selected text only. Exact original publication timestamps remain unverified; relative ages, footer dates and index dates must not substitute. The comment does not itself repeat Bronchogen: reported-name attribution depends on its original placement in the single-compound Bronchogen results thread, preserved as a supporting source. Different publicly visible author from original poster; one comment is one report group, without retaining usernames. Route and co-interventions are unspecified. The ambiguous baseline notation 80/115 is not interpreted as measured blood pressure or assigned a diagnosis. Three distinct publicly visible report groups are counted conservatively; anonymous people, exposures and independence cannot be independently verified.

Preparation: Publicly named Bronchogen preparation; AEDL/ADEL sequence and actual chemical identity unverified. Route: Unspecified in this comment; do not inherit the original poster subcutaneous route.

Read original source ↗

Editorial review 2026-10-10. Clinician review pending.

Human report

Bronchogen: inconclusive firsthand respiratory account

One anonymous firsthand public reporter; outcomes and preparation not independently verified.

Reported findings. Same-author follow-up describes possible slight improvement, while explicitly uncertain whether other things caused it.

Nonresponse. Nearly a week of initial named Bronchogen exposure is described as inconclusive.

Harms. No harms established in the inspected public account; absence of reporting does not establish safety.

Limits. Reported-name Bronchogen exposure only; sequence AEDL versus ADEL, terminal groups, purity and actual preparation are unverified. This does not resolve catalog chemistry or promote different-sequence laboratory studies. Anonymous self-selected firsthand public reporting without controlled comparison or independent assessment; not causal proof, clinical efficacy, a population response rate or established safety. Original bodies were visible through the web tool. Raw HTTP retrieval of these four URLs was not attempted after the prior separately recorded Reddit host403. Full-response hashes are null; excerpt hashes identify selected text only. Exact original publication timestamps remain unverified; relative ages, footer dates and index dates must not substitute. Original post and op6okoh follow-up share the publicly visible author identity and remain one report group. Exact dates/elapsed interval are unverified. Follow-up revises the explanation toward a rib-related issue. It does not document verified lung-disease improvement. Other interventions are unspecified. No harms mentioned in inspected selected account; absence of a report is not evidence of safety. Three distinct publicly visible report groups are counted conservatively; anonymous people, exposures and independence cannot be independently verified.

Preparation: Publicly named Bronchogen preparation; AEDL/ADEL sequence and actual chemical identity unverified. Route: Injection described as pinning; subcutaneous versus intramuscular is unspecified.

Read original source ↗

Editorial review 2026-10-10. Clinician review pending.

Regulatory status, dated 2026-10-09

FDA product approval

not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.

Compounding

not established. Legal compounding eligibility is not established here. Sale or a supplement label does not establish eligibility.

Research

source limited. No matched controlled patient-efficacy study of this exact supplier preparation was verified.

Sport

unknown. Not individually verified against current sport rules. Check the exact ingredients with your sport authority.

How long it lasts, how you store it, listed sizes

This entry doesn’t give a duration in hours. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule.

Half-life on file: no single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule. Follow the label on the vial you hold. This page does not set a throw-away date after you add water.

Risks and mix-ups already on the record

  • Human safety for this exact preparation is incompletely characterized. A lack of reported problems does not establish safety.
  • No complete contraindication list is established for this exact preparation. Review pregnancy, allergies and existing conditions with a clinician.
  • No complete interaction study for this exact preparation is verified. Ingredient combinations are not presumed compatible.

People using PepBear often log: Exact product identity, formulation, dated label and any clinician-directed observations. Record symptoms and changes alongside other medicines, sleep and activity; observations do not establish causation.

Sources

  1. Regulatory context; not efficacy evidence · checked 2026-10-09
  2. Bronchogen: human-derived cell experiments · checked 2026-10-09

Questions people ask

Is Bronchogen FDA-approved?

not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.

Does PepBear pick an amount of Bronchogen?

The calculator turns numbers you type into U-100 units. Trial or label amounts stay as cited facts.

How many units is a listed Bronchogen vial after you add water?

Units = (amount in mcg ÷ (vial mg × 1000 ÷ water mL)) × 100 on a U-100 syringe. Enter the three numbers. The chart shows the same math for each listed vial size and 1, 2 or 3 mL of liquid.

Why flag amounts under 5 units?

A U-100 barrel is easy to misread below about 5 marks. That is a measuring warning. The page does not tell you to take more.

Related cards

Discuss the evidence and unresolved identity or safety questions with a licensed clinician. This entry provides no treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.